Natixis’s ICU Medical ICUI Stock Holding History

Natixis’s Portfolio ICUI Stock Details ICUI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,600	Closed	-$869K	–	1080
2024 Q4	$869K	Buy	+5,600	New	+$947K	0.01%	626
2024 Q3	–	Sell	-1	Closed	-$119	–	1033
2024 Q2	$119	Hold	1	–	–	﹤0.01%	959
2024 Q1	$107	Hold	1	–	–	﹤0.01%	977
2023 Q4	$100	Hold	1	–	–	﹤0.01%	1007
2023 Q3	$119	Hold	1	–	–	﹤0.01%	951
2023 Q2	$178	Buy	+1	New	+$183	﹤0.01%	986
2018 Q4	–	Sell	-29,875	Closed	-$8.45M	–	750
2018 Q3	$8.45M	Buy	+29,875	New	+$8.75M	0.05%	303
2018 Q2	–	Sell	-1,169	Closed	-$295K	–	927
2018 Q1	$295K	Buy	+1,169	New	+$275K	﹤0.01%	751
2017 Q4	–	Sell	-2,125	Closed	-$395K	–	994
2017 Q3	$395K	Buy	+2,125	New	+$371K	﹤0.01%	778
2017 Q2	–	Sell	-1,628	Closed	-$249K	–	895
2017 Q1	$249K	Buy	1,628 +38	+2%	+$5.55K	﹤0.01%	792
2016 Q4	$234K	Buy	+1,590	New	+$230K	﹤0.01%	745

Other funds holding ICUI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Natixis's ICUI Position: Q1 2025 in Review

Natixis sold out of ICU Medical (ICUI) in Q1 2025, closing a stake of 5,600 shares — an estimated $869K sold.

Natixis first reported a position in ICUI in Q4 2016 and held it in 11 quarters. The position peaked at $8.45M in Q3 2018. 281 funds tracked by Wall St. Rank hold ICUI as of Q1 2025.

Natixis reported no remaining ICU Medical position as of Q1 2025 after selling out during the quarter.
Natixis sold 5,600 ICU Medical shares in Q1 2025, an estimated $869K.
Natixis first reported a position in ICU Medical in Q4 2016 and held it in 11 quarters.
Natixis's ICU Medical position peaked at $8.45M in Q3 2018.
281 funds tracked by Wall St. Rank held ICU Medical as of Q1 2025.

Based on Natixis's 13F filing for Q1 2025, filed 14 May 2025.